Bioenergetic variation is related to autism symptomatology

[1]  R. Palmer,et al.  Oxidative Stress Challenge Uncovers Trichloroacetaldehyde Hydrate-Induced Mitoplasticity in Autistic and Control Lymphoblastoid Cell Lines , 2017, Scientific Reports.

[2]  R. Frye,et al.  Thyroid dysfunction in children with autism spectrum disorder is associated with folate receptor α autoimmune disorder , 2017, Journal of neuroendocrinology.

[3]  W. Manucha.  Mitochondrial dysfunction associated with nitric oxide pathways in glutamate neurotoxicity. , 2017, Clinica e investigacion en arteriosclerosis : publicacion oficial de la Sociedad Espanola de Arteriosclerosis.

[4]  R. Frye,et al.  The Effect of Mitochondrial Supplements on Mitochondrial Activity in Children with Autism Spectrum Disorder , 2017, Journal of clinical medicine.

[5]  S. J. James,et al.  Mitochondrial and redox abnormalities in autism lymphoblastoid cells: a sibling control study , 2016, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[6]  R. Frye,et al.  Folinic acid improves verbal communication in children with autism and language impairment: a randomized double-blind placebo-controlled trial , 2016, Molecular Psychiatry.

[7]  R. Frye,et al.  Modulation of mitochondrial function by the microbiome metabolite propionic acid in autism and control cell lines , 2016, Translational Psychiatry.

[8]  R. Frye,et al.  Primary Mitochondrial Disease and Secondary Mitochondrial Dysfunction: Importance of Distinction for Diagnosis and Treatment , 2016, Molecular Syndromology.

[9]  F. Gage,et al.  Alleviation of neuronal energy deficiency by mTOR inhibition as a treatment for mitochondria-related neurodegeneration , 2016, eLife.

[10]  R. Frye,et al.  Blocking and Binding Folate Receptor Alpha Autoantibodies Identify Novel Autism Spectrum Disorder Subgroups , 2016, Front. Neurosci..

[11]  J. M. Bravo-San Pedro,et al.  PINK1 deficiency enhances autophagy and mitophagy induction , 2016, Molecular & cellular oncology.

[12]  R. Frye,et al.  Mitochondrial Dysfunction may explain symptom variation in Phelan-McDermid Syndrome , 2016, Scientific Reports.

[13]  D. Rossignol,et al.  Identification and Treatment of Pathophysiological Comorbidities of Autism Spectrum Disorder to Achieve Optimal Outcomes , 2016, Clinical Medicine Insights: Pediatrics.

[14]  H. McConachie,et al.  Systematic Review of the Measurement Properties of Tools Used to Measure Behaviour Problems in Young Children with Autism , 2015, PloS one.

[15]  L. Schieve,et al.  Estimated Prevalence of Autism and Other Developmental Disabilities Following Questionnaire Changes in the 2014 National Health Interview Survey. , 2015, National health statistics reports.

[16]  C. Korth,et al.  DISC1-dependent Regulation of Mitochondrial Dynamics Controls the Morphogenesis of Complex Neuronal Dendrites , 2015, The Journal of Biological Chemistry.

[17]  A. Legido,et al.  Mitochondrial enzyme dysfunction in autism spectrum disorders; a novel biomarker revealed from buccal swab analysis. , 2015, Biomarkers in medicine.

[18]  A. Baghdadli,et al.  Symptom severity as a risk factor for self-injurious behaviours in adolescents with autism spectrum disorders. , 2015, Journal of intellectual disability research : JIDR.

[19]  E. Allen-Vercoe,et al.  Approaches to studying and manipulating the enteric microbiome to improve autism symptoms , 2015, Microbial ecology in health and disease.

[20]  William Gaetz,et al.  Neuromagnetic Oscillations Predict Evoked-Response Latency Delays and Core Language Deficits in Autism Spectrum Disorders , 2015, Journal of autism and developmental disorders.

[21]  Stepan Melnyk,et al.  Increased Susceptibility to Ethylmercury-Induced Mitochondrial Dysfunction in a Subset of Autism Lymphoblastoid Cell Lines , 2015, Journal of toxicology.

[22]  Dante Mantini,et al.  Structural and functional underconnectivity as a negative predictor for language in autism , 2014, Human brain mapping.

[23]  K. Wallace.  Drug-Induced Mitochondrial Neuropathy in Children , 2014, Journal of child neurology.

[24]  S. Bölte,et al.  Brief Report: “Quick and (not so) Dirty” Assessment of Change in Autism: Cross-Cultural Reliability of the Developmental Disabilities CGAS and the OSU Autism CGI , 2014, Journal of autism and developmental disorders.

[25]  D. Rossignol,et al.  Treatments for Biomedical Abnormalities Associated with Autism Spectrum Disorder , 2014, Front. Pediatr..

[26]  I. Hertz-Picciotto,et al.  Deficits in Bioenergetics and Impaired Immune Response in Granulocytes From Children With Autism , 2014, Pediatrics.

[27]  D. Rossignol,et al.  Evidence linking oxidative stress, mitochondrial dysfunction, and inflammation in the brain of individuals with autism , 2014, Front. Physiol..

[28]  S. J. James,et al.  Oxidative Stress Induces Mitochondrial Dysfunction in a Subset of Autism Lymphoblastoid Cell Lines in a Well-Matched Case Control Cohort , 2014, PloS one.

[29]  A. Legido,et al.  Mitochondrial dysfunction in autism. , 2013, Seminars in pediatric neurology.

[30]  S. J. James,et al.  Metabolic effects of sapropterin treatment in autism spectrum disorder: a preliminary study , 2013, Translational Psychiatry.

[31]  Somer Bishop,et al.  Factors influencing scores on the social responsiveness scale. , 2013, Journal of child psychology and psychiatry, and allied disciplines.

[32]  R. Frye,et al.  Unique acyl-carnitine profiles are potential biomarkers for acquired mitochondrial disease in autism spectrum disorder , 2013, Translational Psychiatry.

[33]  R. Frye.  Biomarkers of Abnormal Energy Metabolism in Children with Autism Spectrum Disorder , 2012 .

[34]  S. J. James,et al.  Evidence of oxidative damage and inflammation associated with low glutathione redox status in the autism brain , 2012, Translational Psychiatry.

[35]  R. Frye.  Novel cytochrome B gene mutations causing mitochondrial disease in autism , 2012, Journal of Pediatric Neurology.

[36]  I. Valencia,et al.  Buccal Swab Analysis of Mitochondrial Enzyme Deficiency and DNA Defects in a Child With Suspected Myoclonic Epilepsy and Ragged Red Fibers (MERRF) , 2012, Journal of child neurology.

[37]  I. Valencia,et al.  Non-invasive evaluation of buccal respiratory chain enzyme dysfunction in mitochondrial disease: comparison with studies in muscle biopsy. , 2012, Molecular genetics and metabolism.

[38]  R. Naviaux,et al.  Autistic disorder with complex IV overactivity: A new mitochondrial syndrome , 2011, Journal of Pediatric Neurology.

[39]  C. Lajonchere,et al.  Genetic heritability and shared environmental factors among twin pairs with autism. , 2011, Archives of general psychiatry.

[40]  S. Bryson,et al.  Using the preschool language scale, fourth edition to characterize language in preschoolers with autism spectrum disorders. , 2011, American journal of speech-language pathology.

[41]  D. Rossignol,et al.  Mitochondrial Dysfunction Can Connect the Diverse Medical Symptoms Associated With Autism Spectrum Disorders , 2011, Pediatric Research.

[42]  I. Valencia,et al.  Response to Correspondence on ‘‘5q14.3 Deletion Manifesting as Mitochondrial Disease and Autism: Case Report’’ , 2011 .

[43]  S. Mayes,et al.  Brief Report: Excellent Agreement Between Two Brief Autism Scales (Checklist for Autism Spectrum Disorder and Social Responsiveness Scale) Completed Independently by Parents and the Autism Diagnostic Interview-Revised , 2011, Journal of autism and developmental disorders.

[44]  D. Rossignol,et al.  Mitochondrial dysfunction in autism spectrum disorders: a systematic review and meta-analysis , 2011, Molecular Psychiatry.

[45]  I. Hertz-Picciotto,et al.  Mitochondrial dysfunction in autism. , 2010, JAMA.

[46]  I. Valencia,et al.  5q14.3 Deletion Manifesting as Mitochondrial Disease and Autism: Case Report , 2010, Journal of child neurology.

[47]  P. Pinton,et al.  Methods to Study PTEN in Mitochondria and Endoplasmic Reticulum. , 2016, Methods in molecular biology.

[48]  S. J. James,et al.  Oxidative stress induces mitochondrial dysfunction in a subset of autistic lymphoblastoid cell lines , 2015, Translational Psychiatry.

[49]  G. Bing,et al.  Cyclooxygenase-2 mediates microglial activation and secondary dopaminergic cell death in the mouse MPTP model of Parkinson's disease , 2006, Journal of Neuroinflammation.

[50]  M. Aman,et al.  Validity of the Aberrant Behavior Checklist in Children with Autism Spectrum Disorder , 2014, Journal of autism and developmental disorders.

[51]  S. Puglisi‐Allegra,et al.  Altered calcium homeostasis in autism-spectrum disorders: evidence from biochemical and genetic studies of the mitochondrial aspartate/glutamate carrier AGC1 , 2010, Molecular Psychiatry.